A pioneering biotechnology company, Trilobio, has secured an impressive $8 million in Seed funding to further enhance its automated robotic laboratory system. This investment round, led by Initialized Capital, features contributions from notable venture capital firms such as Argon Ventures and Lowercarbon Capital. Founded in 2021, Trilobio aims to tackle the prevalent issues of data quality and reproducibility that hinder research efficiency in biological studies. Despite advancements in lab automation, a staggering 77% of biologists struggle with reproducing their own or others' experiments. With this financial boost, Trilobio plans to expand its robotics capabilities and no-code software features, offering an integrated platform for advanced genetic engineering and life science research.
Central to Trilobio's innovation is the Trilobot, a fully programmable robot operated through Trilobio OS, an intelligent no-code protocol design software. The Trilobot can house up to eight interchangeable lab tools, effectively functioning as a compact, self-contained lab. Users can input their research protocols into Trilobio OS much like writing a lab notebook entry, enabling automatic planning and execution without manual intervention. This technology ensures standardized and reproducible workflows across different labs, drastically reducing research design and execution time from weeks to mere minutes.
Trilobio’s mission centers on enhancing research reproducibility and accessibility through advanced automation technologies. By addressing longstanding challenges in data quality and reproducibility, the company aims to revolutionize the field of biology. Its co-founders, Roya Amini-Naieni and Maximilian Schommer, have garnered significant recognition for their innovative contributions. The recent funding will be utilized to bolster the Trilobio Platform's robotic capabilities and software features, paving the way for scalable solutions in genetic engineering and synthetic biology.
The integration of purpose-built lab devices and protocols within a single automated platform marks a pivotal advancement in biological research. Trilobio seeks to provide scientists with the tools necessary to execute research more reliably, swiftly, and accurately. This endeavor not only addresses the inefficiencies in current research practices but also fosters a collaborative environment where experiments can be reproduced and improved upon collectively. By ensuring affordable access to cutting-edge technologies, Trilobio empowers researchers to overcome existing obstacles and achieve groundbreaking scientific milestones.
At the heart of Trilobio's innovation lies the Trilobot, a fully programmable robot designed to perform a wide array of laboratory tasks. Operated via Trilobio OS, an intelligent no-code protocol design software, the Trilobot houses up to eight interchangeable lab device tools, creating a compact, self-contained laboratory environment. These robots automatically calibrate themselves and collaborate seamlessly, adapting to individual research needs and scaling capacity effortlessly.
The Trilobio OS allows users to input their research protocols akin to writing a lab notebook entry, initiating automatic planning and execution processes. This eliminates the need for extensive coding and intricate research design, significantly reducing the time required for workflow execution. By determining the optimal execution parameters for speed, cost, or accuracy, Trilobio OS ensures reproducibility across different laboratories without necessitating hardware recalibration or protocol rewrites. Consequently, researchers can focus more on advancing scientific knowledge rather than wrestling with technical complexities, marking a transformative shift in modern biological research methodologies.